At first blush, recent Phase 3 trial results from the anti-amyloid antibodies gantenerumab and lecanemab seem to be a study in opposites, one negative and one positive. At the 15th Clinical Trials on ...

Opthea's Phase 3 COAST trial for wet AMD failed its primary endpoint, raising concerns about the company's financial stability. Opthea Limited announced that its global Phase 3 trial, COAST, ...

A research team led by The Hong Kong University of Science and Technology (HKUST) scholars has discovered a significant slowdown in Arctic sea ice melting since 2012, with the decrease rate of 11.3% ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

A research team led by The Hong Kong University of Science and Technology (HKUST) scholars has discovered a significant ...